Vox Markets Logo

Renewi on track to meet full-year expectations

10:20, 25th April 2024
Vox News
Company News
TwitterFacebookLinkedIn

Recycling specialist Renewi (RWI) Follow | RWI reiterated full-year guidance on Thursday, following "strong" performances in a number of divisions.
Updating on year-end trading, the waste-to-product firm said group revenues would be slightly lower year-on-year, as expected.

The dip reflected a mixed market backdrop as well as lower recyclate pricing.

However, Renewi continued: "The benefit of ongoing cost reduction, digitisation, execution of strategic initiatives and strong momentum in several of the group's businesses is expected to result in an improved underlying EBIT margin performance in the second half versus the first.

"As a result, the group [anticipates] to report full-year results in line with current market expectations."

In particular, Renewi said there had been "strong" performances in three of its four divisions while the recovery in the Mineralz & Water unit was continuing, with the overall performance slightly ahead of the original recovery plan.

As at 1000 BST, shares in the London-listed firm were up 1% at 558p.

Renewi employs around 6,000 people at multiple sites across Europe. It is due to publish full-year results on 30 May.

Stock Chart | RWI
TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
  • London close: Stocks rise as US payrolls come in weaker

    1 day ago

    London markets closed positively on Friday, as investors digested slower-than-expected payrolls growth in the US, while Anglo American jumped amid anticipation of a potential bidding war for the mining giant.

  • FTSE 250 movers: Trainline rolling; Georgia banks out of favour

    1 day ago

    FTSE 250 (MCX) 20,198.09 0.73%

  • FTSE 100 movers: Anglo rallies on Reuters report; IHG slumps

    1 day ago

    London's FTSE 100 was up 0.5% at 8,209.34 in afternoon trade on Friday.

  • Berenberg raises target price on Standard Chartered

    1 day ago

    Analysts at Berenberg raised their target price on multinational bank Standard Chartered from 1,050.0p to 1,100.0p on Friday after the group's Q1 earnings "validated" management's suggestion that the bank had experienced "an encouraging start" to the year.

  • Citi sees significant upside at Team17

    1 day ago

    Citi has reiterated its 'buy' rating for British video-game developer Team17, saying it sees significant upside to its valuation as operations stabilise.

  • Jefferies downgrades AJ Bell after share price rally

    1 day ago

    Jefferies downgraded its stance on AJ Bell on Friday to 'hold' from 'buy' after a circa 30% rally in the shares this year.

  • Triple Point to sell part of portfolio after shareholder consultation

    1 day ago

    Triple Point Social Housing announced plans to sell part of its portfolio on Friday, following shareholder consultations.

  • Adriatic Metals announces resignation of CFO

    1 day ago

    Adriatic Metals, the FTSE 250 precious and base metals miner, has announced that its chief financial officer is stepping down after just two years on the job.

  • CMA set for deeper probe of Pennon's SES acquisition

    1 day ago

    Pennon Group worked to assure the market that its acquisition of Sutton and East Surrey Water (SES Water) would avoid a deeper competition probe on Friday, telling shareholders that it planned to offer "appropriate undertakings" to regulators.

  • Angle strikes supplier deal with AstraZeneca

    1 day ago

    Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Watchlist